Treatment failure patterns of adjuvant gefitinib therapy and minimal residual disease detection in resected EGFR-mutant non-small cell lung cancer: author’s reply

Detalles Bibliográficos
Autores principales: Xu, Song-Tao, Yin, Jia-Cheng, Xi, Jun-Jie, Wang, Qun, Zhong, Wen-Zhao, Wu, Yi-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082299/
https://www.ncbi.nlm.nih.gov/pubmed/32206565
http://dx.doi.org/10.21037/tlcr.2019.11.14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082299/
https://www.ncbi.nlm.nih.gov/pubmed/32206565
http://dx.doi.org/10.21037/tlcr.2019.11.14

Ejemplares similares